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Chapter 8: Summary, general 





The aim of the research presented in this thesis was to find a cephalosporin acylase with 
activity on β-lactams with adipyl and/or aminoadipyl side chains. These enzymes are 
needed for an efficient production of 7-ADCA and 7-ACA, respectively, two key 
intermediates in the production of semi-synthetic cephalosporins. As β-lactam antibiotics 
are the most used antibiotics group, and cephalosporins constitute a significant portion of 
the total amount of β-lactam antibiotics used, the global demand for semi-synthetic 
cephalosporins is huge. However, the production of these compounds can be improved in 
terms of efficiency, reduction of pollution and costs. 
The production of the related semi-synthetic penicillins is one of the success stories of 
biotechnology [182]. Penicillin G is produced by fermentation of Penicillium 
chrysogenum, and subsequently deacylated to the penicillin intermediate 6-APA by 
penicillin acylase. Finally, a new side chain is coupled to 6-APA to form one of the many 
semi-synthetic penicillins, in a reaction that is also catalyzed by penicillin acylase 
[11,14,15]. The availability of this excellent biocatalyst has been crucial for the scale up 
of this environmentally friendly, cheap and efficient production to an industrial level. 
The problem with cephalosporins lies in the fact that no excellent enzyme is available for 
efficient deacylation of cephalosporin fermentation products. The best route so far to 
obtain the cephalosporin intermediate 7-ACA or 7-ADCA is the two-step enzymatic 
deacylation of CPC, consisting of two separate processes that are catalyzed by two 
enzymes, a D-amino acid oxidase and a cephalosporin acylase. However, such a two-step 
process is far less efficient as two kinds of enzymes must be produced and two bioreactors 
must be prepared independently [83]. Therefore, new processes to obtain the 
intermediates are demanded. A very straightforward method would be the one-step 
enzymatic deacylation of a fermentation product, similar to the production of 6-APA. 
Currently, two cephalosporin fermentation products can be produced on an industrial scale: 
CPC and adipyl-7-ADCA [11,16]. Although adipyl-7-ADCA can be hydrolyzed by a 
cephalosporin acylase on an industrial scale [60-63] the process can be improved. For the 
industrially viable enzymatic hydrolysis of CPC no acylase is available [51]. This thesis 
deals with the search for new and better biocatalysts for these applications. 
 
Strategies for finding a suitable biocatalyst are described in Chapter 1. In short, there are 
four main strategies. Screening of samples from natural sources comprises the testing of 
microorganisms from soil, water or other niches for their performance in the desired 
reaction. The analysis of these samples can be done by screening, in which the 
microorganisms from the sample are isolated and the reaction is performed for each 
isolate, or by selection, in which the right organisms is enriched and isolated from the 
complete sample. The responsible gene(s) can subsequently be cloned and expressed in 
suitable hosts. The second strategy comprises the random mutagenesis of available 
biocatalysts. Enzymes with altered properties can be obtained by altering the gene. The 
main challenge lies in the creation of a mutant library that contains the optimal sequence 
space required for the desired alteration, but is not too large making isolation of the right 
mutant(s) impossible. A third strategy is rational mutagenesis of available enzymes, for 
which a high resolution 3D structure of the enzyme is a prerequisite. Specific alterations 
of the gene can be analyzed in silico in order to come to an enzyme with the desired 
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substrate specificity. The fourth and final strategy is the search for homologous genes in 
genome databases. An enzyme with almost the desired substrate specificity can be used as 
a query for similar enzymes that can be tested in the desired reaction. Finally, Chapter 1 
also gives a small review of the progress that has been made so far in the search for 
biocatalysts that can be implemented in cephalosporin production processes. Screening of 
samples of natural sources has identified many good glutaryl acylases, but not a highly 
active adipyl or CPC acylase. Mutagenesis of cephalosporin acylases has increased the 
activity towards CPC, but by far not enough for industrial use. 
 
Chapter 2 represents a review of the recent advances in the field of β-lactam acylase 
research. Apart from the search for an adipyl or CPC acylase, a major topic is the β-lactam 
acylase catalyzed addition of novel side chains to the intermediates in order to produce 
semi-synthetic β-lactam antibiotics. Novel enzymes for this reaction have been discovered, 
3D structure determination has increased the understanding of the reaction, and protein 
engineering has increased the synthesis activity of available enzymes. The industrial 
applicability of β-lactam acylases has been improved by increasing the stability of β-
lactam acylases by protein engineering, process design and enzyme immobilization. 
Finally, β-lactam acylases have been used to isolate pure enantiomers from racemic 
mixtures by stereospecific acylation/deacylation. Chapter 2 thus provides a background on 
research that goes beyond the finding or generation of a suitable adipyl or CPC acylase. 
 
In Chapter 3 the search for a new biocatalyst in this thesis begins. First, the WT 
cephalosporin acylase from Pseudomonas SY-77 is described, including the isolation of 
the gene, the sequence of the gene and its corresponding protein, and high level 
production in E. coli. Sequence analysis showed that the gene is transcribed as a precursor 
peptide consisting of a Sec-type signal sequence, the α-subunit, a spacer peptide and the 
β-subunit, whereas the active enzyme consists only of the α and β-subunit. The activity of 
the enzyme towards glutaryl-7-ACA, its recognized preferred substrate, was shown to be 
much higher than its activity towards the desired substrate adipyl-7-ADCA. Activity 
towards CPC could not be detected. Clearly, the substrate specificity of the enzyme has to 
be shifted towards the desired substrates. However, complete randomization of the gene 
would result in a far too large mutant library, so a two-step strategy was used for 
mutagenesis. First, random mutagenesis of the α subunit was performed by means of 
spiked oligo mutagenesis. The mutant library was transformed into the serine deficient 
host E. coli PC2051, and plated on agar plates containing adipyl-serine as the sole source 
of serine. The bacterium will have access to serine and grow only if the mutant gene 
encodes an enzyme that is capable to deacylate this substrate. Colonies were selected and 
sequencing showed that most genes contained point mutations of the codons for residues 
177, 178 and 179. However, as codons consist of three basepairs, point mutations of 
basepairs will not substitute these amino acids for all 19 other possible residues. Therefore, 
saturation mutagenesis was performed on the 9 basepairs encoding residues 177 to 179 in 
order to analyze the effect of all amino acids at these positions. The resultant mutant 
library was also selected on adipyl-serine. The two mutagenesis rounds combined resulted 
in 7 unique mutants that were analyzed for activity towards glutaryl-serine and the 
selection substrate adipyl-serine. Three mutants with an improved adipyl/glutaryl activity 




an increased kcat and catalytic efficiency towards the β-lactam substrate adipyl-7-ADCA, 
and a decreased Km. In contrast, mutants SY-77Y179G and SY-77L177I+Y178W+V179M showed 
only a decreased Km and an increased catalytic efficiency, but not an increased kcat. This 
first experiment showed that the activity towards adipyl-7-ADCA can be increased by 
mutagenesis of Pseudomonas SY-77 cephalosporin acylase. Analysis of the 3D structure 
of cephalosporin acylase showed that residue 178 is the only amino acid of the α-subunit 
that is part of the substrate binding site and that a histidine at this position both creates 
extra space for the longer side chain of adipyl-7-ADCA and pulls the side chain deeper 
into the side chain binding pocket. This may explain the observed shift in substrate 
specificity. 
 
After this success, improvements were also expected by mutagenesis of the β-subunit as 
described in Chapter 4. This time, error-prone PCR was used to introduce the point 
mutations and selection was based on leucine deficient host E. coli DH10B and adipyl-
leucine as the selection substrate. Sequencing of the acylase gene of 50 selected mutants 
showed that position 266 was altered 22 times, either as single mutations or as one of 
multiple mutations, and position 375 was altered 3 times. Other positions were mutated 
less frequently. Five mutants showed a significantly increased activity ratio using the β-
lactam substrates adipyl-7-ADCA and glutaryl-7-ACA. These mutants were purified and 
their hydrolysis kinetic parameters for these substrates were determined. Mutant SY-
77N266H showed an eight-fold increased catalytic efficiency towards adipyl-7-ADCA, 
mainly because of a decreased Km. The second most interesting mutant was SY-77F375L, 
which showed a 50% increase of kcat. Its five-fold increased activity ratio was mainly due 
to a decrease of activity towards glutaryl-7-ACA. Analysis of the 3D structure showed 
that all mutated positions are in the vicinity of the substrate binding site and that Phe375 is 
part of the side chain binding site. In contrast, Asn266 does not interact with the substrate 
directly, and had therefore been ignored by competing research groups. Interestingly, the 
three most important residues identified in our random mutagenesis studies form together 
with two other residues a pyramid-like structure that surrounds the carboxylate head of the 
side chain. It is proposed that the binding and hydrolysis of substrates with altered side 
chains requires mutagenesis of these residues of cephalosporin acylase. 
 
Position 375 is analyzed in more detail in Chapter 5. Mutant genes with all 19 other 
amino acids at this position were constructed and all 20 enzymes were purified in high 
amounts from E. coli cultures. Interestingly, not all mutant enzymes were processed 
correctly to the mature α and β-subunits. Mutant SY-77F375P was only obtained as the 
precursor peptide, and mutants SY-77F375R, SY-77F375I, SY-77F375V and SY-77F375T were 
purified as mixtures of the precursor and the completely processed protein. Interestingly, 
no mutants showed a partial processing, which would result in a processed β-subunit and 
an α-subunit with spacer peptide still attached. This is contrary to the current model for 
autocatalytic processing, in which the side chain binding pocket including Phe375 plays 
primarily a role in the second processing step. Four mutations increase the kcat towards 
adipyl-7-ADCA, of which mutant SY-77F375H shows the highest increase, 2.4-fold. The 
Km towards adipyl-7-ADCA was decreased by four mutations, at most 6-fold by mutation 
Phe375Gly. Finally, the catalytic efficiency was increased by five mutations of which 
mutant SY-77F375C shows the biggest increase, 6-fold. The activity of all mutants towards 
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glutaryl-7-ACA is decreased, and none of the mutants show activity towards CPC. 
Interestingly, the substitution of Phe375 by the bulky tryptophan residue or the charged 
residues arginine, aspartic acid and glutamic acid completely abolishes activity towards 
both glutaryl-7-ACA and adipyl-7-ADCA. Analysis of the 3D structure in light of these 
data suggests that position 375 plays a pivotal role in the substrate binding pocket. It is 
situated at the transition area between a hydrophobic ring and a hydrophilic cavity that 
bind the aliphatic alkyl chain of the substrate side chain and the negatively charged 
carboxylate head, respectively. A small hydrophobic residue at position 375 enlarges the 
hydrophobic ring, allowing the better accommodation of the larger adipyl side chain. A 
hydrophilic residue at position 375 becomes part of the hydrophilic cavity and can join in 
the hydrogen bond network, thereby pulling the longer adipyl side chain deeper into the 
pocket, similar to mutation Tyr178His (Chapter 3). Finally, a very bulky residue or a 
charged residue closes the hydrophobic ring for the charged side chain. 
 
The information gathered in Chapters 3, 4 and 5 is used for rational and combined 
rational/random mutagenesis of cephalosporin acylase in Chapter 6. In this project five 
selected residues are randomized, of which three have been separately investigated earlier: 
Tyr178 (Chapter 3; Otten [183]), Asn266 (Chapter 4; Otten et al [100]), Phe375 (Chapters 
4 and 5), and finally Tyr231 and Arg255. These last two residues are part of the side chain 
binding pocket and form hydrogen bonds to the carboxylate head of the side chain of 
glutaryl-7-ACA as described in Chapter 3. Mutagenesis of three of these positions has 
been shown to increase the activity of the enzyme towards adipyl-7-ADCA, and, 
moreover, mutagenesis of positions 178 and 266 has been shown to increase the activity 
of the enzyme towards CPC [100,183]. Analysis of a portion of the obtained library 
showed that three positions, 178, 231 and 375, were completely randomized. Positions 
255 and 266 were mutated to a lesser extent most likely due to a bias in one of the PCR 
subreactions. Since both positions were randomized by the same mutagenic primer, and 
Arg255 seems to be an essential residue for processing and catalytic activity, no 
conclusions can be drawn with regard to position 266. The mutant library was selected on 
aminoadipyl-leucine, the selection derivative of aminoadipyl-7-ACA, i.e. CPC. However, 
only very small colonies were found on the plates, of which none produced an enzyme 
that deacylated β-lactam substrates. In contrast, selection on adipyl-leucine resulted in 
three unique mutants that are better in deacylating adipyl-7-ADCA, SY-77Y178F+F375H, SY-
77Y178F+F375l and SY-77Y178F+F375M. No mutants with an altered residue at position 231 were 
selected, suggesting that this position is already optimal for hydrolysis activity of the 
selection substrate. At position 178 all mutants have a phenylalanine residue. However, 
the single mutant SY-77Y178F does not show an increased kcat towards adipyl-7-ADCA, 
and was discarded in Chapter 3 because it does not have an increased adipyl/glutaryl 
activity ratio. The single mutant does have a strongly decreased Km. Interestingly, the 
increases in catalytic efficiency and kcat of the best mutant SY-77Y178F+F375H are higher 
than was expected from the improvements of both single mutants; the increase is 
synergistic. This mutant shows the best kinetic parameters for adipyl-7-ADCA hydrolysis 
found so far, a 36-fold increased catalytic efficiency due to a 5.8-fold increase of kcat and a 
6-fold decrease of Km. The activity is approaching an industrially applicable height. 
Moreover, the single mutant SY-77Y178F shows a kcat towards glutaryl-7-ACA that is 




application. The results of this combined rational/random mutagenesis were compared to 
the results of a rational recombination study. Two mutants were made, SY-77Y178H+F375H 
and SY-77Y178HF+F375L, combining the mutant of position 178 with the highest kcat value 
(Chapter 3) with the selected mutant at position 375 (Chapter 4) and the mutant at position 
375 with the highest kcat value (Chapter 5). However, these mutants were both worse than 
all selected mutants with regard to catalytic efficiency and Km, and were not as good as 
the best selected mutant in kcat. At least in this case, random mutagenesis of rationally 
chosen positions followed by selection gave better results than rational recombination of 
the best residues at those positions. 
 
Finally, Chapter 7 describes the search for an adipyl or CPC acylase by analyzing 
homologs of the cephalosporin acylase from Pseudomonas SY-77. In a BLAST search 
over 50 homologs of this enzyme were found in the microbial genome projects database, 
including four in the Pseudomonas aeruginosa PAO1 genome. One of these, PA2385, 
could be produced in E. coli. However, no activity was detected when the extracts were 
incubated with several β-lactam substrates. Interestingly, deacylation of acyl-homoserine 
lactone (AHL) substrates could be detected. These compounds are used by Pseudomonas 
and other species in a process named quorum sensing. In this process, each cell produces a 
tiny amount of an AHL compound, and when the cell density reaches a certain value (the 
quorum) the AHL concentration reaches a threshold value. The cells react by altering the 
expression of a number of genes, which will alter the phenotype of the population. In P. 
aeruginosa PAO1 virulence is controlled by quorum sensing, using AHLs that consist of 
the HSL nucleus coupled to a C4 or 3-oxo-C12 aliphatic side chain. The enzyme encoded 
by the homologous gene, PA2385, was purified and showed biochemical characteristics 
similar to the β-lactam acylases, such as subunit composition and reaction type. It was 
clearly not a β-lactam acylase since no activity could be measured on a range of penicillin 
and cephalosporin compounds. A bioassay confirmed that the enzyme could deacylate 
some AHL compounds at the low concentrations that are relevant for quorum sensing. 
Moreover, inhibition of several virulence factors could be observed both when the 
purified enzyme was added to cultures of P. aeruginosa PAO1 as well as when the gene 
was overexpressed in the microorganism. These results suggest a potential role for 
PA2385 in antibacterial treatment. 
 
 
General discussion and outlook 
A quick survey of the results described in this thesis might give the impression that 
random mutagenesis of an available enzyme is the best way to obtain a biocatalyst for a 
novel reaction. However, it should be noted that it is the combination of explorative 
mutagenesis, a powerful selection, input from 3D structure determination and random 
mutagenesis of selected regions that has yielded the best mutants of the biocatalyst. 
Screening of samples from natural sources for β-lactam acylase activity has been done on 
a large scale. Several good glutaryl acylases were found, but only less active adipyl 
acylases and no CPC acylase were obtained. This may be explained from the nature of the 
side chain and the type of reaction. It is very unlikely that enzymes would have evolved 
specifically to deacylate the glutaryl or adipyl β-lactam compounds, as these compounds 
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are not present in nature. Even so it is difficult to envisage an evolutionary advantage for 
CPC hydrolysis, as the β-lactam centre is still intact and functional after deacylation. The 
glutaryl side chain resembles the amino acid glutamic acid [135], and it is tempting to 
speculate that the enzymes have evolved basically as peptidases scavenging for amino 
acids essential to the host. Glutaryl peptidases may have evolved to enzymes that exhibit a 
broad glutaryl peptidase activity including activity on glutaryl cephalosporin. In contrast, 
the adipyl or the aminoadipyl side chains are less essential for bacterial growth and 
therefore it seems logical that in nature no highly active CPC acylase or adipyl acylase has 
evolved. This is where directed evolution can be most useful.  
With regard to the analysis of homologous genes, many putative acylases have been 
identified in the microbial genome projects. We have investigated the four putative 
acylases of P. aeruginosa PAO1. Only three of these could be picked up from the 
chromosomal DNA, of which one could be expressed in E. coli. Even though the enzyme 
turned out to be incapable to deacylate β-lactam compounds, it is very similar to the β-
lactam acylases in its biochemical properties. 
These common aspects may shed some light on the physiological function of 
cephalosporin acylases. Up to now, the physiological function is thought to be in nutrient 
scavenging, similar to the postulated function of penicillin acylase [19]. The results of 
chapter 7 suggest a regulatory role in quorum quenching, as the putative acylase from P. 
aeruginosa PAO1 is able to hydrolyze AHL signal molecules. In this regard, it should be 
noted that the penicillin acylase from Streptomyces lavendulae shows a high activity 
towards penicillin K and penicillin dihydroF [90], which have uncharged aliphatic side 
chains of eight and six carbon atoms, respectively. This enzyme has not been tested yet 
for activity towards AHL compounds, but may very well be an AHL acylase. Similarly, 
the lipopeptide acylases, for example from Actinoplanes utahensis [184], may also be 
AHL acylases. These acylases deacylate antifungal compounds such as aculeacin A and 
echinocandin B, which have side chains that are very similar to the side chains of some 
AHL compounds, and usually consist of a uncharged aliphatic side chain of 18 carbon 
atoms, sometimes with unsaturated bonds. Likewise, cephalosporin acylases may degrade 
quorum sensing signal molecules with dicarboxylic acid side chains that have not been 
discovered yet. 
Up to now, four different functions have been demonstrated for genes homologous to 
cephalosporin acylase genes: deacylation of penicillins, cephalosporins, AHL compounds 
and cyclic lipopeptides. All of these reactions comprise the hydrolysis of an amide bond 
that connects a ring-like nucleus to a side chain, aromatic in the first and aliphatic in the 
latter three examples. Therefore, on the basis of sequence alone it cannot be predicted 
what the substrate specificities of putative acylases will be, provided that they are indeed 
acylases. A comprehensive screening should be conducted. 
In the 308 investigated microbial genomes over 80 putative acylases are identified (d.d. 
May 24, 2004), of which some will probably be β-lactam acylases. Narrowing the search 
to the family of Pseudomonadaceae, as most acylases identified so far were found in 
Pseudomonas species, results in 26 putative acylases. Testing for β-lactam acylase activity 
has not been reported, with the exception of one (chapter 7). In Figure 1 a phylogenetic 
tree is shown of the putative Pseudomonas acylases and the acylases with known function. 
The putative acylases fall in three clusters, with the exception of the second gene from P. 




gene PAO1 1, has homologs in all sequenced Pseudomonas species, and is related to the 
AHL acylase from Ralstonia XJ12B and to the lipopeptide acylases. The relation to the 
SY-77 cephalosporin acylase family is quite distant. Gene PAO1 2 may encode a β-lactam 
acylase as it is clustered in the phylogenetic tree with the SE-83 AcyII family and the 
cephalosporin acylase from Pseudomonas A14. PAO1 3 and PAO1 4 are not closely 
related to any of the acylases with known function. With regard to the metagenome 
strategy, some genes showing high homology to Pseudomonas SY-77 cephalosporin 
acylase can also be found in a BLAST search of the environmental samples from the 
Sargasso sea and a mine drainage (http://www.ncbi.nlm.nih.gov/BLAST/Genome/ 
Figure 1. Phylogenetic tree of acylase homologs from Pseudomonaceae and 
acylase homologs of known function. 
AHL acylase = acyl-homoserine lactone acylase, ca = cephalosporin acylase, cla = 
cyclic lipopeptide acylase, pga = penicillin G acylase. For P. aeruginosa the genes from 
strain PAO1 are used, those from strain UCBPP-PA14 are virtually identical. For P. 
fluorescens strain SBW25 is used, representing also the genes from strains Pf-5 and 
PfO-1, for P. putida strain KT2440 is used, and for P. syringae strain pv. syringae 
B728a is used representing strains pv. phaseolicola 1448A and strain pv. tomato str. 
DC3000 as well. The cephalosporine acylases from Pseudomonas SY-77 and SE-83 
represent also their homologs as shown in Chapter 1, Table 2 and Figure 4. Alignment 
made as described for Figure 4 of Chapter 1, sequences obtained via a search at 
http://www.ncbi.nlm.nih.gov/BLAST/. 
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EnvirSamplesBlast.html) (d.d. May 24, 2004). Clearly, these databases contain a treasure 
of putative acylases that can be tested, and using other cephalosporin acylases than the 
Pseudomonas SY-77 enzyme as query will only increase the number of candidate genes. 
A set of highly homologous genes thus obtained will also enable family shuffling, in 
which selected genes are randomly recombined to form new genes [185] that may encode 
a cephalosporin acylase with the desired substrate specificity. As shuffle experiments 
typically generate large mutant libraries, the selection system based on selective growth 
described in this thesis will be of utmost importance. 
Good progress has been achieved by mutagenesis of the available cephalosporin acylase 
from Pseudomonas SY-77. The size of the analyzed mutant libraries, >1x104 each, clearly 
indicates that selection of the mutant libraries is highly preferable over screening of all 
mutants. However, even when a good selection method is available the number of mutants 
can quickly become too large to handle. Therefore, a three-step strategy was used to 
decrease the number of mutants. First, random point mutagenesis identified residues 
useful for increasing the activity towards adipyl-7-ADCA. Subsequent saturation 
mutagenesis of these positions identified the best amino acids for these positions in single 
mutants and, perhaps more importantly, increased the understanding of the interactions 
between the enzyme and different substrates. Finally, simultaneous randomization of a set 
of chosen residues resulted in the best mutant found in the project. 
The results described in this thesis allow to draw some conclusions on generating an 
adipyl or CPC acylase from Pseudomonas SY-77 cephalosporin acylase. An alignment of 
all known two-subunit acylases and most putative acylases show that the tyrosine residue 
at position 231 is strongly conserved in all acylases. Moreover, no variants with mutations 
at position 231 were selected, even in the randomization of positions 178, 231 and 375 
(chapter 6), in which all possible combinations of mutants at these positions should have 
been created. Thus, Tyr231 does not necessarily have to be included in the set of residues 
to be mutated. 
Positions 178, 266 and 375 are very important to alter the substrate specificity of the 
enzyme, and should always be included in the set of residues to be mutated. However, the 
rational combination of the best single mutations at these positions does not result in the 
best possible mutants (chapter 6 and [183]). In order to obtain an optimal acylase, these 
residues should be simultaneously randomized. This was attempted in chapter 6, but 
unfortunately the mutant library did not show a good randomization of position 266. A 
proper mutagenesis of these residues should result in a very versatile acylase. 
Positions that can be added to the set of residues to be mutated include Leu222, Val268, 
Gln248 and Tyr351. Leu222 and Val268 form together with Phe375 the hydrophobic ring 
that interacts with the alkyl part of the side chain. Alterations in the ring will allow the 
longer side chain of adipyl-7-ADCA or CPC to adopt alternative configurations, so that 
the longer side chain can be accommodated without driving the amide bond from its 
optimal position for a nucleophilic attack by Ser199 (chapter 5). Gln248 and Tyr351 are 
part of the hydrophilic cavity that interacts with the carboxylate head of glutaryl-7-ACA. 
These residues do not form direct hydrogen bonds to the substrate, but interact with 
residues that do. Gln248 forms a hydrogen bond with the essential Arg255, and Tyr351 is 
the bridge between Asn266 and Arg255. However, as a mutant library in which residues 
Tyr178, Leu222, Tyr231, Gln248, Arg255, Asn266, Val268, Tyr351 and Phe375 are 




mutants, and 329 = 3.5x1013 if NNS codons are used. These mutant libraries cannot be 
created and analyzed using the methods described in this thesis. Therefore, different 
strategies are needed. A first approach is the correct randomization of the “pyramid” set of 
residues described in chapter 4. A second approach would be to first optimize the 
hydrophilic cavity by randomizing Tyr178, Gln248, Arg255, Asn266 and Tyr351. The 
best mutants from this library can subsequently be optimized with respect to the 
hydrophobic interactions by randomizing Leu222, Val268 and Phe375. This can be 
followed by another round of randomizing the hydrophilic residues, etc. A third strategy 
would be the randomization of all 9 residues simultaneously, but to replace hydrophilic 
residues with hydrophilic residues and hydrophobic with hydrophobic in order to decrease 
the size of the mutant library. To this end, mixtures of primers containing the 11 
hydrophilic amino acids at the position to be randomized, or the 9 hydrophobic amino 
acids, should replace the primers with NNS codons. The size of the mutant library for the 
9 positions would then be 116 x 93 = 1.3x109, and 115x93 = 1.2x108 if Tyr231 is discarded. 
The latter mutant library is large but workable. 
Rational mutagenesis of cephalosporin acylase by molecular modeling is hampered by the 
orientation of residue Phe375 in the crystallographic model. It is the only residue that is in 
a disallowed region in the crystal structure of cephalosporin acylase and adopted different 
configurations during each modeling attempt in our department. Since such an important 
residue cannot be modeled correctly, it is very hard to explain the observed effects of 
mutations, let alone predict them. Crystal structure determination of a number of Phe 
mutants is required for reliable rational design of an adipyl or CPC acylase based on 
cephalosporin acylase. 
A preliminary screening of the activity towards β-lactam compounds of selected mutants 
is essential, but is hampered by the fact that no inhibitor is available to estimate the 
concentration of acylase enzyme in the cell free extracts. The only known inhibitor of 
cephalosporin acylase is bromoacetyl-7-ACA, which is unfortunately not commercially 
available and the inactivation seems to be time-dependent [48,101]. This problem is 
circumvented in this thesis by determination of the adipyl over glutaryl ratio, but this may 
lead to false negatives as it was seen for mutant SY-77Y178F. 
In conclusion, a biocatalyst to perform the one-step deacylation of adipyl-7-ADCA to 
intermediates for the industrial production of semi-synthetic cephalosporins can definitely 
be found. An CPC acylase will be harder to find. Saturation mutagenesis of rationally 
selected residues of Pseudomonas SY-77 cephalosporin acylase seems to be the most 
effective strategy. 
